Literature DB >> 16987501

Involvement of nitric oxide synthase and ROS-mediated activation of L-type voltage-gated Ca2+ channels in NMDA-induced DPYSL3 degradation.

Renata Kowara1, Kristoffer Laser Moraleja, Balu Chakravarthy.   

Abstract

Dihydropyrimidinase-like 3 (DPYSL3), a member of TUC (TOAD-64/Ulip/CRMP), is believed to play a role in neuronal differentiation, axonal outgrowth and possibly in neuronal regeneration. Recently, we have shown that in primary cortical neurons (PCN) NMDA and oxidative stress (H(2)O(2)) caused a calpain-dependent cleavage of DPYSL3 (62 kDa) resulting in the appearance of a lower molecular weight form (60 kDa) of DPYSL3. Our preliminary results had shown that antioxidants significantly reduced NMDA-induced DPYSL3 degradation, indicating involvement of ROS in calpain activation. The aim of this study was to investigate the possible involvement of NOS in NMDA-induced DPYSL3 degradation. We found that NOS inhibitor (L-NAME) significantly prevented NMDA-induced ROS formation, as well as intracellular Ca(2+) increase [Ca(2+)](i), DPYSL3 degradation and cell death. Further, exposure of PCN to NO donor (SNP) resulted in significant [Ca(2+)](i) increase, ROS generation and probable calpain-mediated DPYSL3 truncation. The NMDA- and oxidative stress (ROS)-induced DPYSL3 truncation was totally dependent on extracellular [Ca(2+)](i). While NMDA-induced DPYSL3 truncation was blocked by both NMDA receptor antagonist (MK801) [Kowara, R., Chen, Q., Milliken, M., Chakravarthy, B., 2005. Calpain-mediated degradation of dihydropyrimidinase-like 3 protein (DPYSL3) in response to NMDA and H(2)O(2) toxicity. J. Neurochem. 95 (2), 466-474] and L-VGCC (nimodipine) inhibitors, H(2)O(2)-induced increase in [Ca(2+)](i), ROS generation and DPYSL3 truncation was blocked only by nimodipine. These results indicate that changes in Ca(2+) homeostasis resulting from ROS-dependent activation of L-VGCC are sufficient to induce probable calpain-mediated DPYSL3 truncation and demonstrate for the first time the role of ROS in the mechanism leading to glutamate-induced calpain activation and DPYSL3 protein degradation. The probable calpain-mediated DPYSL3 truncation may have significant impact on its interaction with actin and its assembly, and in turn on growth cone integrity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987501     DOI: 10.1016/j.brainres.2006.08.047

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Authors:  José M A Moreira; Teresa Cabezón; Irina Gromova; Pavel Gromov; Vera Timmermans-Wielenga; Isidro Machado; Antonio Llombart-Bosch; Niels Kroman; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2010-10-08       Impact factor: 6.603

2.  Neuroprotective effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against oxidative stress.

Authors:  Hanwook Kim; Hyo Jeong Son; Seung Cheol Ha; Eun-A Kim; Tae Ue Kim; Soo Young Choi; Jee-Yin Ahn; Sung-Woo Cho
Journal:  Cell Mol Neurobiol       Date:  2011-05-27       Impact factor: 5.046

3.  Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.

Authors:  Zhongjian Cheng; Xiaohua Jiang; Meghana Pansuria; Pu Fang; Jietang Mai; Karthik Mallilankaraman; Rajesh Kumar Gandhirajan; Satoru Eguchi; Rosario Scalia; Muniswamy Madesh; Xiaofeng Yang; Hong Wang
Journal:  Diabetes       Date:  2014-10-28       Impact factor: 9.461

4.  The Effect of Noscapine on Oxygen-Glucose Deprivation on Primary Murine Cortical Neurons in High Glucose Condition.

Authors:  Gelareh Vahabzadeh; Soltan-Ahmed Ebrahimi; Nahid Rahbar-Roshandel; Massoud Mahmoudian
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Collapsin Response Mediator Protein 4 (CRMP4) Facilitates Wallerian Degeneration and Axon Regeneration following Sciatic Nerve Injury.

Authors:  Marie-Pier Girouard; Tristan Simas; Luyang Hua; Barbara Morquette; Mohamad R Khazaei; Nicolas Unsain; Aaron D Johnstone; Isabel Rambaldi; Ricardo L Sanz; Marie-Eve Di Raddo; Kanchana K Gamage; Yu Yong; Dianna E Willis; Valerie M K Verge; Philip A Barker; Christopher Deppmann; Alyson E Fournier
Journal:  eNeuro       Date:  2020-03-02

6.  Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.

Authors:  Wei Sun; Bing Wang; Xing-Long Qu; Bi-Qiang Zheng; Wen-Ding Huang; Zheng-Wang Sun; Chun-Meng Wang; Yong Chen
Journal:  Cells       Date:  2019-12-30       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.